{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T19:17:00Z","timestamp":1770146220072,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:sec>\n                <jats:title>Hintergrund<\/jats:title>\n                <jats:p>Aufgrund von Arzneimittelnebenwirkungen, Medikamenteninteraktionen oder wegen inad\u00e4quater Wirkung bei der Behandlung mit Opioiden kann eine Opioidrotation indiziert sein. Zur Bestimmung der oralen Morphin\u00e4quivalenz ist mit der Leitlinie \u201eLangzeitanwendung von Opioiden bei chronischen nicht-tumorbedingten Schmerzen (LONTS)\u201c ein Praxiswerkzeug ver\u00f6ffentlicht. Dem gegen\u00fcber stehen mehrere Apps, die bislang nicht bewertet wurden.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material und Methoden<\/jats:title>\n                <jats:p>Mittels Google Play Store\u00ae, iOS App Store\u00ae und der Suchmaschine Google\u00ae wurden Apps zur Opioidkonversion gesucht. Deutsch- und englischsprachige Apps mit Kalkulatorfunktion wurden eingeschlossen. Mit den Apps wurden 16\u00a0Testf\u00e4lle aus der klinischen Praxis kalkuliert und die Abweichung von der Empfehlung der LONTS-Leitlinie berechnet.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ergebnisse<\/jats:title>\n                <jats:p>Insgesamt wurden 17\u00a0Apps identifiziert. Elf benannten die Herkunft des Algorithmus, 3\u00a0davon benannten Literaturquellen. Keine App wies ein Qualit\u00e4tssiegel auf, zudem lie\u00dfen sich mit keiner App s\u00e4mtliche F\u00e4lle l\u00f6sen. Es wurden Abweichungen der resultierenden oralen Morphin\u00e4quivalente um +179\u202f% von der leitliniengerechten Umrechnung identifiziert. Vier Apps warnten vor \u00dcberdosierungen.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Schlussfolgerung<\/jats:title>\n                <jats:p>Obwohl die Apps die Umrechnung zwischen Opioiden vereinfachen, besteht eine hohe Varianz der Umrechnungsfaktoren und teils eine gro\u00dfe Abweichung von evidenzbasierten Tabellen. Insgesamt besteht ein hohes Risiko von Opioidfehldosierungen.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00482-022-00683-5","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T10:02:47Z","timestamp":1670839367000},"page":"290-296","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Unterst\u00fctzung der Opioidrotation mithilfe von Online-Apps","Support of opioid rotation using online apps"],"prefix":"10.1007","volume":"37","author":[{"given":"Jan D.","family":"Wandrey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niklas","family":"Behnel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sascha","family":"Tafelski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"683_CR1","doi-asserted-by":"publisher","DOI":"10.24355\/dbbs.084-201210110913-53","volume-title":"Chancen und Risiken von Gesundheits-Apps (CHARISMHA)","author":"U-V Albrecht","year":"2016","unstructured":"Albrecht\u00a0U\u2011V (2016) Chancen und Risiken von Gesundheits-Apps (CHARISMHA) https:\/\/doi.org\/10.24355\/dbbs.084-201210110913-53"},{"key":"683_CR2","doi-asserted-by":"publisher","first-page":"e10394","DOI":"10.2196\/10394","volume":"6","author":"U-V Albrecht","year":"2018","unstructured":"Albrecht\u00a0U\u2011V, Hillebrand\u00a0U, von Jan\u00a0U (2018) Relevance of trust marks and CE labels in German-language store descriptions of health apps: analysis. JMIR Mhealth Uhealth 6:e10394. https:\/\/doi.org\/10.2196\/10394","journal-title":"JMIR Mhealth Uhealth"},{"key":"683_CR3","unstructured":"DiAntonio W (2015) Do people click on the second page of Google? Reputation 911. https:\/\/reputation911.com\/do-people-click-past-the-first-page-of-google\/. Zugegriffen: 09.11.2022"},{"key":"683_CR4","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jpainsymman.2009.06.002","volume":"38","author":"PG Fine","year":"2009","unstructured":"Fine\u00a0PG, Portenoy\u00a0RK, Ad Hoc Expert Panel on Evidence Review and Guidelines for Opioid Rotation (2009) Establishing \u201ebest practices\u201c for opioid rotation: conclusions of an expert panel. J\u00a0Pain Symptom Manage 38:418\u2013425. https:\/\/doi.org\/10.1016\/j.jpainsymman.2009.06.002","journal-title":"J Pain Symptom Manage"},{"key":"683_CR5","first-page":"A-346","volume":"115","author":"K Gie\u00dfelmann","year":"2018","unstructured":"Gie\u00dfelmann\u00a0K (2018) Leitlinien-Apps: Keine zentrale Pr\u00fcfung in Sicht. Dtsch Arztebl Int 115:A-346","journal-title":"Dtsch Arztebl Int"},{"key":"683_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s40264-013-0015-0","volume":"36","author":"F Haffey","year":"2013","unstructured":"Haffey\u00a0F, Brady\u00a0RRW, Maxwell\u00a0S (2013) A comparison of the reliability of smartphone apps for opioid conversion. Drug Saf 36:111\u2013117. https:\/\/doi.org\/10.1007\/s40264-013-0015-0","journal-title":"Drug Saf"},{"key":"683_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s00482-020-00472-y","volume":"34","author":"W H\u00e4user","year":"2020","unstructured":"H\u00e4user\u00a0W, Bock\u00a0F, H\u00fcppe\u00a0M et\u00a0al (2020) Empfehlungen der zweiten Aktualisierung der Leitlinie LONTS. Schmerz 34:204\u2013244. https:\/\/doi.org\/10.1007\/s00482-020-00472-y","journal-title":"Schmerz"},{"key":"683_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/cpt196012163","volume":"1","author":"RW Houde","year":"1960","unstructured":"Houde\u00a0RW, Wallenstein\u00a0SL, Rogers\u00a0A (1960) Clinical pharmacology of analgesics. 1. A method of assaying analgesic effect. Clin Pharmacol Ther 1:163\u2013174. https:\/\/doi.org\/10.1002\/cpt196012163","journal-title":"Clin Pharmacol Ther"},{"key":"683_CR9","volume-title":"Vergleich der Marktanteile von Android und iOS am Absatz von Smartphones in Deutschland von Januar 2012 bis Juni 2022","author":"Kantar","year":"2022","unstructured":"Kantar (2022) Vergleich der Marktanteile von Android und iOS am Absatz von Smartphones in Deutschland von Januar 2012 bis Juni 2022. Statista"},{"key":"683_CR10","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jpainsymman.2009.06.001","volume":"38","author":"H Knotkova","year":"2009","unstructured":"Knotkova\u00a0H, Fine\u00a0PG, Portenoy\u00a0RK (2009) Opioid rotation: the science and the limitations of the equianalgesic dose table. J\u00a0Pain Symptom Manage 38:426\u2013439. https:\/\/doi.org\/10.1016\/j.jpainsymman.2009.06.001","journal-title":"J Pain Symptom Manage"},{"key":"683_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.26164\/leopoldina_10_00346","volume":"423","author":"I Kopp","year":"2021","unstructured":"Kopp\u00a0I (2021) AWMF: is the transformation of evidence through digitalization possible? Nova Acta Leopoldina NAL Con 423:69\u201375. https:\/\/doi.org\/10.26164\/leopoldina_10_00346","journal-title":"Nova Acta Leopoldina NAL Con"},{"key":"683_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/J354v19n04_05","volume":"19","author":"RA Lugo","year":"2005","unstructured":"Lugo\u00a0RA, Satterfield\u00a0KL, Kern\u00a0SE (2005) Pharmacokinetics of methadone. J\u00a0Pain Palliat Care Pharmacother 19:13\u201324","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"683_CR13","unstructured":"Recktenwald\u00a0L (2017) Realit\u00e4ts-Check\u00a0\u2013 Nutzen \u00c4rzte Health Apps? coliquio. https:\/\/www.coliquio-insights.de\/nutzen-aerzte-health-apps-exklusive-umfrage\/. Zugegriffen: 09.11.2022"},{"key":"683_CR14","unstructured":"Schnabel A, Rittner H (2018) Opioidrotation in der Praxis \u2013 was, warum und wie? Arzneiverordn Prax 45. https:\/\/www.akdae.de\/arzneimitteltherapie\/arzneiverordnung-in-der-praxis\/ausgaben-archiv\/ausgaben-ab-2015\/ausgabe\/artikel\/2018\/2018-01\/opioidrotation-in-der-praxis-was-warum-und-wie. Zugegriffen: 09.11.2022"},{"key":"683_CR15","first-page":"A-1874","volume":"115","author":"A Schnabel","year":"2018","unstructured":"Schnabel\u00a0A, Rittner\u00a0H (2018) Schmerztherapie: T\u00fccken der Opioidrotation in der t\u00e4glichen Routine. Dtsch Arztebl Int 115:A-1874","journal-title":"Dtsch Arztebl Int"},{"key":"683_CR16","first-page":"45","volume":"110","author":"I Schubert","year":"2013","unstructured":"Schubert\u00a0I, Ihle\u00a0P, Sabatowski\u00a0R (2013) Zunahme der Opioidverordnungen in Deutschland zwischen 2000 und 2010. Dtsch Arztebl Int 110:45\u201351","journal-title":"Dtsch Arztebl Int"},{"key":"683_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jpainsymman.2009.06.004","volume":"38","author":"PE Shaheen","year":"2009","unstructured":"Shaheen\u00a0PE, Walsh\u00a0D, Lasheen\u00a0W et\u00a0al (2009) Opioid equianalgesic tables: are they all equally dangerous? J\u00a0Pain Symptom Manage 38:409\u2013417. https:\/\/doi.org\/10.1016\/j.jpainsymman.2009.06.004","journal-title":"J Pain Symptom Manage"},{"key":"683_CR18","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s00482-015-0018-0","volume":"30","author":"S Tafelski","year":"2016","unstructured":"Tafelski\u00a0S, Beutlhauser\u00a0T, Bellin\u00a0F et\u00a0al (2016) Auftreten von Obstipation bei Patienten mit ambulanter Opioidtherapie. Schmerz 30:158\u2013165. https:\/\/doi.org\/10.1007\/s00482-015-0018-0","journal-title":"Schmerz"},{"key":"683_CR19","volume-title":"World health organization model list of essential medicines","author":"World Health Organization","year":"2019","unstructured":"World Health Organization (2019) World health organization model list of essential medicines"},{"key":"683_CR20","unstructured":"(2022) S3 Leitlinie \u201eBehandlung akuter perioperativer und posttraumatischer Schmerzen\u201c."}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-022-00683-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00482-022-00683-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-022-00683-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T13:05:53Z","timestamp":1690290353000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00482-022-00683-5"}},"subtitle":["Evaluation der Anwendbarkeit und Vergleich mit der LONTS-Leitlinie","Evaluation of applicability and comparison to the LONTS guidelines"],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["683"],"URL":"https:\/\/doi.org\/10.1007\/s00482-022-00683-5","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"9 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.D.\u00a0Wandrey: kein Interessenkonflikt zum spezifischen Gegenstand dieser Untersuchung. Aktive T\u00e4tigkeiten in Arbeitskreisen und Kommissionen: Deutsche Schmerzgesellschaft e.\u202fV., Berlin (Co-Sprecher Arbeitskreis Junge Schmerzgesellschaft; Mitglied Ad-hoc-Kommission Studienordnungen), Deutsche Gesellschaft f\u00fcr An\u00e4sthesiologie und Intensivmedizin e.\u202fV. (DGAI; wissenschaftlicher Arbeitskreis Schmerzmedizin, Arbeitsgruppe Kommunikation). Forschungsf\u00f6rderung durch den Nachwuchsf\u00f6rderpreis Schmerz 2021, F\u00f6rderung von \u201earticle processing charges\u201c durch die Deutsche Forschungsgemeinschaft (DFG) und den Open Access Publication Fonds der Charit\u00e9 \u2013\u00a0Universit\u00e4tsmedizin Berlin sowie Reisekostenf\u00f6rderung durch den Verein der Freunde und F\u00f6rderer der Berliner Charit\u00e9 e.\u202fV. und die Deutsche Schmerzgesellschaft e.\u202fV. N.\u00a0Behnel: kein Interessenkonflikt zum spezifischen Gegenstand dieser Untersuchung. Reisekostenf\u00f6rderung durch den Verein der Freunde und F\u00f6rderer der Berliner Charit\u00e9 e.\u202fV. und die Deutsche Schmerzgesellschaft e.\u202fV. S.\u00a0Tafelski: kein Interessenkonflikt zum spezifischen Gegenstand dieser Untersuchung. Aktive T\u00e4tigkeiten in Arbeitskreisen und Kommissionen der Deutschen Schmerzgesellschaft e.\u202fV. sowie der DGAI e.\u202fV., DFG-F\u00f6rderung f\u00fcr \u201earticle processing charges\u201c \u00fcber den Open Access Publication Fonds der Charit\u00e9\u00a0\u2013 Universit\u00e4tsmedizin Berlin.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}